MannKind Corp (NASDAQ:MNKD)
| CAPS Rating |
|
|---|---|
| Open | $2.37 |
| Previous Close | $2.41 |
| Daily Range | $2.25 - $2.38 |
| 52-Week Range | $2.14 - $5.24 |
| Market Cap | $305.16M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 2,028,507 |
| Average Daily Volume | 0 |
MNKD
VS S&P 500 (SPY)
How do you think MNKD will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MNKD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MNKD News and Commentary
- Why Did My Stock Just Die? – The Motley Fool
- 5 of Last Week's Biggest Losers – The Motley Fool
- The Week's Biggest Stock Laggards – The Motley Fool
- MannKind Treads the Neutral Path - Analyst Blog – NASDAQ
- The Worst Health Care Stocks of 2011 – The Motley Fool
- 2011 No Dreamboat for MannKind – The Motley Fool
- Here's What Some Big-Time Quants Are Buying – The Motley Fool
- MannKind in Neutral Lane - Analyst Blog – NASDAQ
- 7 Black Friday Biotech Bargains – The Motley Fool
- The Highest-Rated Biopharma Stocks – The Motley Fool
- January Effect Boosting Stock Prices: Here Are the Possible Winners – The Motley Fool
- These 2 Biotechs Got Crushed – The Motley Fool
- Biotech Blunder Turned 20% Overnight Gain – The Motley Fool
- Against the Herd: If Everyone Else is Selling Stocks, Should You? – NASDAQ
- 5 Superball Stocks – The Motley Fool
- Against the Herd: If Everyone Else Is Selling Stocks, Should You? – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- A Drug Market That's 366 Million Strong – The Motley Fool
- Investors Guide to the New PDUFA – The Motley Fool
- 3 Stocks Stopping the Presses – The Motley Fool
RSS Headlines
Fool UK
